Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle D Tate

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Immunology and Cell Biology|November 20, 2025
Myeloid cell-derived NLRP3 is dispensable for silica-induced pulmonary inflammation and pathologyKristian T Barry, Christopher M Harpur, Rebecca L Ambrose, et al.
Particle and Fibre Toxicology|May 3, 2026
Epithelial NLRP3 drives silica-induced lung injury and fibrosis through IL-18 and pro-fibrotic neutrophil recruitmentMaggie Lam, Kristian T Barry, Christopher J Hodges, et al.
Cell Death & Disease|November 9, 2023
Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infectionSarah Rosli, Christopher M Harpur, Maggie Lam, et al.
Clinical & Translational Immunology|March 27, 2023
Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infectionChristopher M Harpur, Alison C West, Mélanie A Le Page, et al.
Virology|September 7, 2010
Gr-1+ cells, but not neutrophils, limit virus replication and lesion development following flank infection of mice with herpes simplex virus type-1Magdalena Wojtasiak, Danielle L Pickett, Michelle D Tate, et al.
Journal of Virology|November 22, 2013
The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virusWy Ching Ng, Stella Liong, Michelle D Tate, et al.
Plos Pathogens|June 6, 2013
Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and diseaseJulie L McAuley, Michelle D Tate, Charley J MacKenzie-Kludas, et al.
Mucosal Immunology|January 25, 2026
Short-course intranasal LAT9997 therapy limits post-influenza bacterial pneumonia by recalibrating lung immunityAlison C West, Christopher M Harpur, Maggie Lam, et al.
The Journal of Infectious Diseases|December 7, 2023
Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe InfluenzaAlison C West, Christopher M Harpur, Mélanie A Le Page, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamiliesEmma R Job, Yi-Mo Deng, Michelle D Tate, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Immunology and Cell Biology|November 20, 2025
Myeloid cell-derived NLRP3 is dispensable for silica-induced pulmonary inflammation and pathologyKristian T Barry, Christopher M Harpur, Rebecca L Ambrose, et al.
Particle and Fibre Toxicology|May 3, 2026
Epithelial NLRP3 drives silica-induced lung injury and fibrosis through IL-18 and pro-fibrotic neutrophil recruitmentMaggie Lam, Kristian T Barry, Christopher J Hodges, et al.
Cell Death & Disease|November 9, 2023
Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infectionSarah Rosli, Christopher M Harpur, Maggie Lam, et al.
Clinical & Translational Immunology|March 27, 2023
Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infectionChristopher M Harpur, Alison C West, Mélanie A Le Page, et al.
Virology|September 7, 2010
Gr-1+ cells, but not neutrophils, limit virus replication and lesion development following flank infection of mice with herpes simplex virus type-1Magdalena Wojtasiak, Danielle L Pickett, Michelle D Tate, et al.
Journal of Virology|November 22, 2013
The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virusWy Ching Ng, Stella Liong, Michelle D Tate, et al.
Plos Pathogens|June 6, 2013
Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and diseaseJulie L McAuley, Michelle D Tate, Charley J MacKenzie-Kludas, et al.
Mucosal Immunology|January 25, 2026
Short-course intranasal LAT9997 therapy limits post-influenza bacterial pneumonia by recalibrating lung immunityAlison C West, Christopher M Harpur, Maggie Lam, et al.
The Journal of Infectious Diseases|December 7, 2023
Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe InfluenzaAlison C West, Christopher M Harpur, Mélanie A Le Page, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamiliesEmma R Job, Yi-Mo Deng, Michelle D Tate, et al.
Pageof 8